Follow-up studies in a human lung cancer xenograft mouse model showed that CD103 is induced upon T cell trafficking to tumors, and that in vivo neutralization of TGF-β impairs the recruitment of CD103+ CD8 T cells into the TME (73). This evidence concerns the gene ITGAE and lung carcinoma.